Jorge M Aguiar-Geraldo, Bruno Spalenza da Silva, Taise Possamai-Della, Maria Luísa Machado-Laureano, Aline Vitoreti-Vargas, João Quevedo, Samira S Valvassori
{"title":"莫达非尼对记忆和脑氧化应激的影响:健康大鼠急性和慢性给药的对比效果。","authors":"Jorge M Aguiar-Geraldo, Bruno Spalenza da Silva, Taise Possamai-Della, Maria Luísa Machado-Laureano, Aline Vitoreti-Vargas, João Quevedo, Samira S Valvassori","doi":"10.1007/s11011-025-01600-2","DOIUrl":null,"url":null,"abstract":"<p><p>The present study assessed the impact of modafinil (MD) on memory function and oxidative damage in the brains of naive rats. Wistar rats were administered either a single dose or repeated doses (over 30 days) of water or MD (75, 150, or 300 mg/kg) via gavage. The novel object recognition (NOR), open-field habituation (OFH), and inhibitory avoidance task (IA) tested the animals' memory. Furthermore, the oxidative and nitrosative stress markers (4-hydroxynonenal [4-HNE], 8-isoprostane [8-ISO], 3-nitrotyrosine [3-nitro], superoxide dismutase [SOD], and catalase [CAT]) were assessed in the frontal cortex, hippocampus and striatum of the rats. The acute administration of MD did not affect any memory measures or oxidative stress parameters evaluated in this study. In contrast, chronic MD administration at a dose of 300 mg/kg decreased memory related to habituation and recognition. In addition, chronic administration of this drug increased oxidative lipid damage, evaluated through 8-ISO and 4-HNE. These findings suggest a potential link between chronic MD use, memory impairment, and oxidative stress in the brains of rats, emphasizing the importance of further research in this area.</p>","PeriodicalId":18685,"journal":{"name":"Metabolic brain disease","volume":"40 5","pages":"191"},"PeriodicalIF":3.5000,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The impact of modafinil on memory and brain oxidative stress: contrasting effects of acute and chronic administration in healthy rats.\",\"authors\":\"Jorge M Aguiar-Geraldo, Bruno Spalenza da Silva, Taise Possamai-Della, Maria Luísa Machado-Laureano, Aline Vitoreti-Vargas, João Quevedo, Samira S Valvassori\",\"doi\":\"10.1007/s11011-025-01600-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The present study assessed the impact of modafinil (MD) on memory function and oxidative damage in the brains of naive rats. Wistar rats were administered either a single dose or repeated doses (over 30 days) of water or MD (75, 150, or 300 mg/kg) via gavage. The novel object recognition (NOR), open-field habituation (OFH), and inhibitory avoidance task (IA) tested the animals' memory. Furthermore, the oxidative and nitrosative stress markers (4-hydroxynonenal [4-HNE], 8-isoprostane [8-ISO], 3-nitrotyrosine [3-nitro], superoxide dismutase [SOD], and catalase [CAT]) were assessed in the frontal cortex, hippocampus and striatum of the rats. The acute administration of MD did not affect any memory measures or oxidative stress parameters evaluated in this study. In contrast, chronic MD administration at a dose of 300 mg/kg decreased memory related to habituation and recognition. In addition, chronic administration of this drug increased oxidative lipid damage, evaluated through 8-ISO and 4-HNE. These findings suggest a potential link between chronic MD use, memory impairment, and oxidative stress in the brains of rats, emphasizing the importance of further research in this area.</p>\",\"PeriodicalId\":18685,\"journal\":{\"name\":\"Metabolic brain disease\",\"volume\":\"40 5\",\"pages\":\"191\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-04-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Metabolic brain disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11011-025-01600-2\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic brain disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11011-025-01600-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
The impact of modafinil on memory and brain oxidative stress: contrasting effects of acute and chronic administration in healthy rats.
The present study assessed the impact of modafinil (MD) on memory function and oxidative damage in the brains of naive rats. Wistar rats were administered either a single dose or repeated doses (over 30 days) of water or MD (75, 150, or 300 mg/kg) via gavage. The novel object recognition (NOR), open-field habituation (OFH), and inhibitory avoidance task (IA) tested the animals' memory. Furthermore, the oxidative and nitrosative stress markers (4-hydroxynonenal [4-HNE], 8-isoprostane [8-ISO], 3-nitrotyrosine [3-nitro], superoxide dismutase [SOD], and catalase [CAT]) were assessed in the frontal cortex, hippocampus and striatum of the rats. The acute administration of MD did not affect any memory measures or oxidative stress parameters evaluated in this study. In contrast, chronic MD administration at a dose of 300 mg/kg decreased memory related to habituation and recognition. In addition, chronic administration of this drug increased oxidative lipid damage, evaluated through 8-ISO and 4-HNE. These findings suggest a potential link between chronic MD use, memory impairment, and oxidative stress in the brains of rats, emphasizing the importance of further research in this area.
期刊介绍:
Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to physicians, neuroscientists, internists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders.